Expert Feasibility Assessment for over 20 Years

Attentive selection and evaluation of the investigator and site are key to a clinical trial’s success.
Man Reading

Feasibility

Feasibility Assessment is an essential first step before conducting any clinical trial.

Clinical trial feasibility facilitates the process of selecting country, sites and investigators, as well as patient recruitment strategies.

Sponsors contact Dokumeds for specialist regional feasibilities and management of global feasibility studies. We perform extensive qualitative reviews of the information we gather. Open source databases, publications and relationships with key opinion leaders provide valuable information, but nothing replaces information acquired on the ground, confirmed in real time.

Key assessment factors

  • Geographical potentiality
  • Regulatory related risks
  • Patient population to determine capacity and speed of enrollment
  • Risks in patient recruitment
  • Availability of referral networks
  • Investigator/site interest
  • Investigator/site experience in conducting clinical trials
  • Availability of qualified site personnel
  • Availability of equipment/facilities required by to the protocol
  • Gap between protocol and standard of care
  • Additional sponsor requirements

Clinical trial feasibility is a core initial step for any clinical study.

Experienced team:

Dokumeds’ specialized feasibility team is led by our medical director, an experienced medical professional skilled in evaluating medical information and study protocols. Regulatory, pharmacovigilance and financial specialists join the team when necessary, and external experts are consulted if needed. Our multifunctional team is responsible for identifying specific countries, sites and investigators in order to develop a strategy to meet enrollment targets and complete your project on time and on budget.

Benefits of feasibility:

Clinical trial feasibilities allow sponsors to determine potential challenges in advance and plan accordingly. They give sponsors and CROs the opportunity to assess a multitude of factors so that your project is initiated and completed efficiently and with minimal risks.

The feasibility process:

The feasibility process begins as soon as a client approaches Dokumeds with a request for proposal for a clinical trial. We evaluate the enrollment and treatment phase from various perspectives — medical, operational, regulatory and logistics, bridging the gap between study protocol and standard of care. This includes thoroughly reviewing study design, inclusion/exclusion criteria, patient resources, health care environment and site readiness. Critical analysis of gathered information is particularly important to identify potential site and study related risks.

Dokumeds Feasibility Group

Feasibility Manager Cycle

Dokumeds Feasibility Process

Dokumeds Feasibility Process

Connected services

Regulatory affairs
Practice-based regulatory consulting expertise, and support throughout the product life cycle.
Learn more
Pharmacovigilance Icon
Pharmacovigilance
We deliver high-quality solutions, with services designed to ensure patient safety at every stage of the drug life cycle.
Learn more
Clinical Operations Icon
Clinical Operations
Our highly nuanced approach that accounts for the specific needs of each project.
Learn more
Patient Recruitment
Patient Recruitment
We have a golden track record of meeting recruitment targets for sponsors.
Learn more

News for Patient Recruitment

Lorem ipsum dolor sit amet, consectetur adipiscing elit.
The Importance of Scientific Advice from the Regulatory Authorities in Clinical Research
The process of marketing authorization is a crucial step in the entire drug development process. Deciphering the most...
Learn more
Ebook’s title comes right here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas interdum gravida purus quis dictum.
Learn more
Ebook’s title comes right here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas interdum gravida purus quis dictum.
Learn more

Read More